Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome

Bibliographic Details
Main Authors:	Amrita Goyal, MD, Damodaran Narayanan, MBBS, PhD, Waihay Wong, MD, PhD, Alvaro C. Laga, MD, Nathan T. Connell, MD, MPH, Susan Y. Ritter, MD, PhD, Gabriela Cobos, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-05-01
Series:	JAAD Case Reports
Subjects:	autoinflammatory myelodysplasia relapsing polychondritis tocilizumab UB1A ubiquitination
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622001072

Internet